Angelica Peebles, Bloomberg, March 6, 2023 Moderna Inc. is eyeing possible human testing of shots to fight mpox and bird flu this year, as the Covid-19 vaccine maker expands into more public-health immunizations. The company is exploring messenger RNA vaccines …
Transplants Force Patients to Amass Vaccinations to Beat COVID
Elaine Chen, Bloomberg, June 1, 2021 For Jennifer Woda, two doses of the Moderna Inc. vaccine were not enough protection against the Covid-19 virus. Over a month later, she got a third and fourth dose, this time with the Pfizer Inc.–BioNTech SE vaccine. An …